|
RPS6KA3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.48280004625457E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.29370003388152E-09 |
| Normal-vs-Stage2 |
4.301500E-02 |
| Normal-vs-Stage3 |
7.62069999999948E-05 |
| Normal-vs-Stage4 |
5.037900E-03 |
| Stage1-vs-Stage2 |
2.664000E-01 |
| Stage1-vs-Stage3 |
3.639600E-01 |
| Stage1-vs-Stage4 |
5.064000E-01 |
| Stage2-vs-Stage3 |
6.885800E-01 |
| Stage2-vs-Stage4 |
7.263200E-01 |
| Stage3-vs-Stage4 |
9.980000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.36659999877753E-08 |
| Normal-vs-AfricanAmerican |
9.663000E-03 |
| Normal-vs-Asian |
2.159100E-04 |
| Caucasian-vs-AfricanAmerican |
9.917800E-01 |
| Caucasian-vs-Asian |
1.874020E-01 |
| AfricanAmerican-vs-Asian |
4.425600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.93999999999717E-05 |
| Normal-vs-Female |
5.88329995832026E-09 |
| Male-vs-Female |
2.714000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.9221999547625E-09 |
| Normal-vs-Age(41-60Yrs) |
2.19379999999436E-05 |
| Normal-vs-Age(61-80Yrs) |
6.264100E-03 |
| Normal-vs-Age(81-100Yrs) |
1.027580E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.365900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.134000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.199800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.208000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.218400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.213200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.079400E-01 |
| Classical-VS-Follicular |
8.644400E-04 |
| Classical-VS-Other |
1.241040E-01 |
| Classical-VS-Normal |
1.10059961144771E-10 |
| Tall-VS-Follicular |
6.551900E-02 |
| Tall-VS-Other |
9.588100E-02 |
| Tall-VS-Normal |
4.401500E-04 |
| Follicular-VS-Other |
6.638600E-01 |
| Follicular-VS-Normal |
6.671800E-02 |
| Other-VS-Normal |
7.003200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.9550999999991E-05 |
| Normal-vs-N1 |
1.449630E-02 |
| N0-vs-N1 |
8.686000E-01 |
|
|
